Marshall Fordyce
CEO, President at Vera Therapeutics, Inc. (VERA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $9.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 17SEC | VERAVera Therapeutics, Inc. | Sell Plan | 18,500235,244 held (−7%) | $37.00 | $684K | -19.2% |
| Sep 4SEC | VERAVera Therapeutics, Inc. | Sell Plan | 18,500235,244 held (−7%) | $35.12 | $650K | -14.9% |
| Aug 12SEC | VERAVera Therapeutics, Inc. | Sell Plan | 14,219239,525 held (−6%) | $36.64 | $521K | -18.4% |
| Aug 12SEC | VERAVera Therapeutics, Inc. | Sell Plan | 4,281235,244 held (−2%) | $37.09 | $159K | -19.4% |
| Aug 12SEC | VERAVera Therapeutics, Inc. | Sell Plan | 1,000280,494 held (−0%) | $40.78 | $41K | -26.7% |
| Aug 12SEC | VERAVera Therapeutics, Inc. | Sell Plan | 32,550247,944 held (−12%) | $42.07 | $1.4M | -29.0% |
| Aug 12SEC | VERAVera Therapeutics, Inc. | Sell Plan | 10,500237,444 held (−4%) | $42.86 | $450K | -30.3% |
| Aug 12SEC | VERAVera Therapeutics, Inc. | Sell Plan | 2,200235,244 held (−1%) | $43.59 | $96K | -31.5% |
| Aug 12SEC | VERAVera Therapeutics, Inc. | Sell Plan | 18,412235,332 held (−7%) | $37.93 | $698K | -21.2% |
| Aug 12SEC | VERAVera Therapeutics, Inc. | Sell Plan | 88235,244 held (−0%) | $38.43 | $3K | -22.2% |
| Jul 9SEC | VERAVera Therapeutics, Inc. | Sell Plan | 1,000197,244 held (−1%) | $40.78 | $41K | -26.7% |
| Jul 9SEC | VERAVera Therapeutics, Inc. | Sell Plan | 32,550164,694 held (−17%) | $42.07 | $1.4M | -29.0% |
| Jul 9SEC | VERAVera Therapeutics, Inc. | Sell Plan | 10,500154,194 held (−6%) | $42.86 | $450K | -30.3% |
| Jul 9SEC | VERAVera Therapeutics, Inc. | Sell Plan | 2,200151,994 held (−1%) | $43.59 | $96K | -31.5% |
| Jun 24SEC | VERAVera Therapeutics, Inc. | Sell Plan | 18,412198,332 held (−8%) | $37.93 | $698K | -21.2% |
| Jun 24SEC | VERAVera Therapeutics, Inc. | Sell Plan | 88198,244 held (−0%) | $38.43 | $3K | -22.2% |
| May 13SEC | VERAVera Therapeutics, Inc. | Sell Plan | 14,219221,025 held (−6%) | $36.64 | $521K | -18.4% |
| May 13SEC | VERAVera Therapeutics, Inc. | Sell Plan | 4,281216,744 held (−2%) | $37.09 | $159K | -19.4% |
| Apr 15SEC | VERAVera Therapeutics, Inc. | Sell Plan | 14,130244,065 held (−5%) | $43.66 | $617K | -31.6% |
| Apr 15SEC | VERAVera Therapeutics, Inc. | Sell Plan | 7,921236,144 held (−3%) | $44.58 | $353K | -33.0% |
| Apr 15SEC | VERAVera Therapeutics, Inc. | Sell Plan | 900235,244 held (−0%) | $45.51 | $41K | -34.3% |
| Feb 25SEC | VERAVera Therapeutics, Inc. | Sell | 16,925257,163 held (−6%) | $41.98 | $711K | -28.8% |
- Sell
CEO, President Marshall Fordyce sold $684K of VERA at $37.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Marshall Fordyce sold $650K of VERA at $35.12 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Marshall Fordyce sold $521K of VERA at $36.64 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Marshall Fordyce sold $159K of VERA at $37.09 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Marshall Fordyce sold $41K of VERA at $40.78 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Marshall Fordyce sold $1.4M of VERA at $42.07 — pre-scheduled 10b5-1 plan sale.